aspsirna1811 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna1811
siRNA Name: s13
Gene:Coagulation factor III (thromboplastin, tissue factor) (F3) /CD142
Disease:Malignant melanoma
Wild allele/target (5'->3'): GCGCUUCAGGCACUACAAAUA
Mutant allele/target (5'->3'):GCGCUUCAGGCAGUACAAAUA
Target Mutation: c.489G>A,p.Arg163=
Wild siRNA (As strand):CGCGAAGUCCGUGAUGUUUAU
ASP-siRNA (As strand):CGCGAAGUCCGUCAUGUUUAU
Mismatch position in siRNA: C9G
Mutant allele (5'->3'): GCGCUUCAGGCAGUACAAAUA
ASP-siRNA (As strand):CGCGAAGUCCGUCAUGUUUAU
ASP-siRNA efficacy for mutant allele:NA
Wild allele (5'->3'): GCGCUUCAGGCACUACAAAUA
ASP-siRNA (As strand):CGCGAAGUCCGUCAUGUUUAU
ASP-siRNA efficacy for wild allele:NA
Percentage discrimination for ASP-siRNA:NA
Wild allele (5'->3'): GCGCUUCAGGCACUACAAAUA
Wild siRNA (As strand):CGCGAAGUCCGUGAUGUUUAU
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): GCGCUUCAGGCACUACAAAUA
ASP-siRNA (As strand):CGCGAAGUCCGUCAUGUUUAU
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:100nM
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: Q99081
Target sequence: AGGTGGCCGGCGCTTCAGGCACTACAAATACTGTGG
Genbank Accesion: NM_001178096.1
Cell-line: HaCaT
Experimental technique used: Northern blot
Transfection method: Lipofectamine 2000
siRNA expression method: Glen Research,PerSeptive Biosystems
Post-transfection duration: 48 hours
OMID ID: 134390
KEGG disease ID:NA
Reference:12527766
siRNA Id:aspsirna1811
siRNA Name: siCD46
Gene:Complement regulatory protein (CD46)
Disease:Hemolytic uremic syndrome
Wild allele/target (5'->3'): CUUAUUGGAGAGAGCACGA
Mutant allele/target (5'->3'):CUUAUUGGUGAGAGCACGA
Target Mutation: c.104G>A, p.Cys35Tyr
Wild siRNA (As strand):GAAUAACCUCUCUCGUGCU
ASP-siRNA (As strand):GAAUAACCUCUCUCGUGCU
Mismatch position in siRNA: U:U clash
Mutant allele (5'->3'): CUUAUUGGUGAGAGCACGA
ASP-siRNA (As strand):GAAUAACCUCUCUCGUGCU
ASP-siRNA efficacy for mutant allele:15
Wild allele (5'->3'): CUUAUUGGAGAGAGCACGA
ASP-siRNA (As strand):GAAUAACCUCUCUCGUGCU
ASP-siRNA efficacy for wild allele:93
Percentage discrimination for ASP-siRNA:78
Wild allele (5'->3'): CUUAUUGGAGAGAGCACGA
Wild siRNA (As strand):GAAUAACCUCUCUCGUGCU
Wild sirna efficacy for wild allele:93
Wild allele (5'->3'): CUUAUUGGAGAGAGCACGA
ASP-siRNA (As strand):GAAUAACCUCUCUCGUGCU
Wild sirna efficacy for mutant allele:15
Percentage discrimination for wild siRNA:78
Concentration:13nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P15529
Target sequence: GCCCCCAATATGTGAAAAG
Genbank Accesion: NM_002389.4
Cell-line: HEK293
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Dharmacon
Post-transfection duration: 24 hours
OMID ID: 120920
KEGG disease ID:H00106, H0027
Reference:15781493

.
.
.
.
.
.
.
.
.
.
.

.

.

.